1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data Triangulation
& Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global ADME
Toxicology Testing Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Technology
(Cell Culture, OMICS Tech, High Throughput, Molecular Imaging)
5.2.2.
By Application (Neurotoxicity, Renal
Toxicity, Systemic Toxicity, Hepatotoxicity, others)
5.2.3.
By Method (Cellular Assay, In-Silica,
Biochemical Assay, Ex-vivo)
5.2.4.
By Region
5.2.5.
By Company (2023)
5.3. Market Map
6.
Asia Pacific ADME
Toxicology Testing Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
By Technology
6.2.2.
By Application
6.2.3.
By Method
6.2.4.
By Country
6.3. Asia Pacific: Country Analysis
6.3.1.
China ADME
Toxicology Testing Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Technology
6.3.1.2.2.
By Application
6.3.1.2.3.
By Method
6.3.2.
India ADME
Toxicology Testing Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Technology
6.3.2.2.2.
By Application
6.3.2.2.3.
By Method
6.3.3.
Australia ADME
Toxicology Testing Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Technology
6.3.3.2.2.
By Application
6.3.3.2.3.
By Method
6.3.4.
Japan ADME
Toxicology Testing Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Technology
6.3.4.2.2.
By Application
6.3.4.2.3.
By Method
6.3.5.
South Korea ADME
Toxicology Testing Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Technology
6.3.5.2.2.
By Application
6.3.5.2.3.
By Method
7.
Europe ADME
Toxicology Testing Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Technology
7.2.2.
By Application
7.2.3.
By Method
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
France ADME Toxicology
Testing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technology
7.3.1.2.2.
By Application
7.3.1.2.3.
By Method
7.3.2.
Germany ADME
Toxicology Testing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technology
7.3.2.2.2.
By Application
7.3.2.2.3.
By Method
7.3.3.
Spain ADME
Toxicology Testing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technology
7.3.3.2.2.
By Application
7.3.3.2.3.
By Method
7.3.4.
Italy ADME
Toxicology Testing Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Technology
7.3.4.2.2.
By Application
7.3.4.2.3.
By Method
7.3.5.
United Kingdom ADME
Toxicology Testing Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Technology
7.3.5.2.2.
By Application
7.3.5.2.3.
By Method
8.
North America ADME
Toxicology Testing Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Technology
8.2.2.
By Application
8.2.3.
By Method
8.2.4.
By Country
8.3. North America: Country Analysis
8.3.1.
United States ADME
Toxicology Testing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technology
8.3.1.2.2.
By Application
8.3.1.2.3.
By Method
8.3.2.
Mexico ADME
Toxicology Testing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technology
8.3.2.2.2.
By Application
8.3.2.2.3.
By Method
8.3.3.
Canada ADME
Toxicology Testing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technology
8.3.3.2.2.
By Application
8.3.3.2.3.
By Method
9.
South America ADME
Toxicology Testing Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Technology
9.2.2.
By Application
9.2.3.
By Method
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil ADME
Toxicology Testing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technology
9.3.1.2.2.
By Application
9.3.1.2.3.
By Method
9.3.2.
Argentina ADME
Toxicology Testing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technology
9.3.2.2.2.
By Application
9.3.2.2.3.
By Method
9.3.3.
Colombia ADME
Toxicology Testing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technology
9.3.3.2.2.
By Application
9.3.3.2.3.
By Method
10.
Middle East and Africa
ADME Toxicology Testing Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Technology
10.2.2.
By Application
10.2.3.
By Method
10.2.4. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa ADME Toxicology Testing Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Technology
10.3.1.2.2.
By Application
10.3.1.2.3.
By Method
10.3.2. Saudi Arabia ADME Toxicology Testing Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Technology
10.3.2.2.2.
By Application
10.3.2.2.3.
By Method
10.3.3. UAE ADME Toxicology Testing Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Technology
10.3.3.2.2.
By Application
10.3.3.2.3.
By Method
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers &
Acquisitions
13. Global ADME Toxicology Testing Market: SWOT Analysis
14.
Porter’s Five Forces
Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Product
15. PESTLE Analysis
16. Competitive Landscape
16.1.
Thermo Fisher
Scientific Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Promega Corporation
16.2.1. Business Overview
16.2.2. Company Snapshot
16.2.3. Products & Services
16.2.4. Financials (In case of listed companies)
16.2.5. Recent Developments
16.2.6. SWOT Analysis
16.3. Agilent Technologies, Inc.
16.3.1. Business Overview
16.3.2. Company Snapshot
16.3.3. Products & Services
16.3.4. Financials (In case of listed companies)
16.3.5. Recent Developments
16.3.6. SWOT Analysis
16.4.
Miltenyi Biotec
16.4.1. Business Overview
16.4.2. Company Snapshot
16.4.3. Products & Services
16.4.4. Financials (In case of listed companies)
16.4.5. Recent Developments
16.4.6. SWOT Analysis
16.5.
Curia Global, Inc.
16.5.1. Business Overview
16.5.2. Company Snapshot
16.5.3. Products & Services
16.5.4. Financials (In case of listed companies)
16.5.5. Recent Developments
16.5.6. SWOT Analysis
16.6.
Dassault Systèmes
16.6.1. Business Overview
16.6.2. Company Snapshot
16.6.3. Products & Services
16.6.4. Financials (In case of listed companies)
16.6.5. Recent Developments
16.6.6. SWOT Analysis
16.7.
Beckman Coulter, Inc., (Danaher)
16.7.1. Business Overview
16.7.2. Company Snapshot
16.7.3. Products & Services
16.7.4. Financials (In case of listed companies)
16.7.5. Recent Developments
16.7.6. SWOT Analysis
16.8.
Catalent, Inc
16.8.1. Business Overview
16.8.2. Company Snapshot
16.8.3. Products & Services
16.8.4. Financials (In case of listed companies)
16.8.5. Recent Developments
16.8.6. SWOT Analysis
16.9.
Charles River Laboratories
16.9.1. Business Overview
16.9.2. Company Snapshot
16.9.3. Products & Services
16.9.4. Financials (In case of listed companies)
16.9.5. Recent Developments
16.9.6. SWOT Analysis
16.10.GE HealthCare
16.10.1. Business Overview
16.10.2. Company Snapshot
16.10.3. Products & Services
16.10.4. Financials (In case of listed companies)
16.10.5. Recent Developments
16.10.6. SWOT Analysis
17.
Strategic Recommendations
18.
About Us &
Disclaimer